Can hypothyroidism contribute to cataract formation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Hypothyroidism Contribute to Cataracts?

Yes, hypothyroidism causally contributes to age-related cataract formation and should be recognized as a modifiable risk factor for cataract development.

Evidence for Causal Relationship

The most recent and highest quality evidence comes from a 2024 Mendelian randomization study that definitively establishes hypothyroidism as a causal determinant of age-related cataract risk 1. This genetic epidemiology study analyzed 337,159 subjects and found that genetically predicted hypothyroidism increases cataract risk substantially (OR = 2.501,95% CI: 1.325-4.720; P = 0.004). The strength of this evidence lies in the Mendelian randomization design, which uses genetic variants as instrumental variables to establish causality rather than mere association—effectively mimicking a randomized controlled trial using genetic data.

The key finding: hypothyroidism increases the risk of age-related cataracts by approximately 2.5-fold.

Clinical Context and Mechanism

While the 2022 American Academy of Ophthalmology Cataract Preferred Practice Pattern guidelines extensively discuss metabolic risk factors for cataracts—including diabetes mellitus, hypertension, obesity, and metabolic syndrome 2—hypothyroidism is notably absent from their list of established risk factors. This represents a gap in current guideline recognition despite emerging genetic evidence.

The biological plausibility is supported by:

  • Metabolic disturbances affecting lens protein homeostasis
  • Oxidative stress mechanisms similar to other endocrine disorders
  • Disrupted phosphocalcium metabolism that can affect lens clarity 3

Clinical Implications

For Screening and Prevention

  • Screen hypothyroid patients for cataracts earlier and more frequently, particularly those under 65 years of age where metabolic effects may be more pronounced
  • Optimize thyroid hormone replacement therapy as a potential strategy to reduce cataract risk, though direct evidence for this intervention is lacking
  • Consider hypothyroidism screening in patients presenting with early or unexplained cataract formation

Important Caveats

The evidence specifically demonstrates causality for hypothyroidism, not hyperthyroidism. A separate 2024 Mendelian randomization study found that hyperthyroidism also increases cataract risk (OR = 361.09) 4, but this was not the focus of your question. Neither circulating free T4 nor TSH levels alone showed significant causal effects on cataracts 1, suggesting the clinical syndrome of hypothyroidism—rather than isolated hormone levels—drives the risk.

Pediatric Considerations

Children with congenital hypothyroidism show high rates of ophthalmic pathology (40.4%), though primarily refractive errors and strabismus rather than cataracts 5. However, this underscores the importance of comprehensive ophthalmologic screening in hypothyroid populations across all ages.

Practical Recommendations

When evaluating patients with hypothyroidism:

  • Document baseline visual acuity and perform dilated fundoscopic examination to assess lens clarity
  • Counsel patients that their thyroid condition increases cataract risk
  • Ensure adequate thyroid hormone replacement per endocrinology guidelines 6
  • Monitor for visual symptoms suggesting cataract development

When evaluating patients with cataracts:

  • Include thyroid function testing (TSH at minimum) in the metabolic workup, particularly for patients under 65 or with early-onset cataracts
  • Recognize that treating hypothyroidism may be part of a comprehensive approach to modifiable risk factors, alongside managing diabetes, hypertension, and smoking cessation 2

The evidence establishes hypothyroidism as a causal, modifiable risk factor for cataracts that warrants clinical attention in both endocrinology and ophthalmology practice.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.